Notch pathway promotes ovarian cancer growth and migration via CXCR4/SDF1α chemokine system

Ahmad, 2011, Regulation angiogenesis by Notch signaling: implication in neovascular age-related macular degeneration, Invest. Ophtalmol. Vis. Sci., 52, 2868, 10.1167/iovs.10-6608 Barbolina, 2010, Microenvironmental regulation of chemokine (C-X-C-Motif) receptor 4 in ovarian carcinoma, Mol. Cancer Res., 8, 653, 10.1158/1541-7786.MCR-09-0463 Bignotti, 2007, Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes, Am. J. Obstet. Gynecol., 196, e1, 10.1016/j.ajog.2006.10.874 Buonamici, 2009, CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia, Nature, 459, 1000, 10.1038/nature08020 Cancer Genome Atlas Research Network, 2011. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609–615. Choi, 2008, Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion, Cancer Res., 68, 5716, 10.1158/0008-5472.CAN-08-0001 Colombo, 2013, Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes, Leukemia, 27, 1009, 10.1038/leu.2013.6 Colombo, 2014, Notch signaling drives multiple myeloma induced osteoclastogenesis, Oncotarget, 5, 10393, 10.18632/oncotarget.2084 Fortini, 2002, Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling, Nat. Rev. Mol. Cell Biol., 3, 673, 10.1038/nrm910 Galic, 2013, NOTCH2 expression is decreased in epithelial ovarian cancer and is related to the tumor histological subtype, Pathol. Discov., 1, 4, 10.7243/2052-7896-1-4 Groeneweg, 2014, Notch signaling in serous ovarian cancer, J. Ovarian Res., 7, 95, 10.1186/s13048-014-0095-1 Hopfer, 2005, The Notch pathway in ovarian carcinomas and adenomas, Br. J. Cancer, 93, 709, 10.1038/sj.bjc.6602719 Hori, 2013, Notch signaling at a glance, J. Cell Sci., 126, 2135, 10.1242/jcs.127308 Hoshino, 2005, A novel role for Notch ligand Delta-1 as a regulator of human Langerhans cell development from blood monocytes, J. Leukoc. Biol., 78, 921, 10.1189/jlb.1204746 Hu, 2011, Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer, Cancer Res., 71, 6030, 10.1158/0008-5472.CAN-10-2719 Hu, 2014, Notch3 pathway alterations in ovarian cancer, Cancer Res., 74, 3282, 10.1158/0008-5472.CAN-13-2066 Ivan, 2013, Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer, Gynecol. Oncol., 128, 506, 10.1016/j.ygyno.2012.11.029 Jarriault, 1995, Signalling downstream of activated mammalian Notch, Nature, 377, 355, 10.1038/377355a0 Jiang, 2006, Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression, Gynecol. Oncol., 103, 226, 10.1016/j.ygyno.2006.02.036 Jung, 2010, Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma, Cancer Sci., 101, 1977, 10.1111/j.1349-7006.2010.01641.x Jurisic, 2011, TNF-α induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells, J. Membr. Biol., 239, 115, 10.1007/s00232-010-9309-7 Kajiyama, 2008, Involvment of SDF-1α/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma, Int. J. Cancer, 122, 91, 10.1002/ijc.23083 Kang, 2005, Eosinophilic differentiation is promoted by blockage of Notch signaling with a gamma-secretase inhibitor, Eur. J. Immunol., 35, 2982, 10.1002/eji.200526242 Kluk, 2013, Gauging NOTCH1 activation in cancer using immunohistochemistry, PLoS ONE, 8, e67306, 10.1371/journal.pone.0067306 Kopan, 2009, The canonical Notch signaling pathway: unfolding the activation mechanism, Cell, 137, 216, 10.1016/j.cell.2009.03.045 Ledermann, 2010, Targeted trials in ovarian cancer, Gynecol. Oncol., 119, 151, 10.1016/j.ygyno.2010.05.008 Maerki, 2006, Induction of chemokine receptor expression during early stage a of T cell development, Immunol. Lett., 104, 110, 10.1016/j.imlet.2005.11.002 Mirandola, 2013, Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1, Leukemia, 27, 1558, 10.1038/leu.2013.27 Mirandola, 2012, Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia, J. Pathol., 226, 713, 10.1002/path.3015 Oktem, 2012, Cancer stem cell and embryonic development-associated molecules contribute to prognostic significance in ovarian cancer, Int. J. Gynecol. Cancer, 22, 23, 10.1097/IGC.0b013e31823228b2 Park, 2006, Notch3 gene amplification in ovarian cancer, Cancer Res., 66, 6312, 10.1158/0008-5472.CAN-05-3610 Pissarra, 2000, Expression of hes6, a new member of the Hairy/Enhancer-of-split family, in mouse development, Mech. Dev., 95, 275, 10.1016/S0925-4773(00)00348-8 Popple, 2012, The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer, Br. J. Cancer, 106, 1306, 10.1038/bjc.2012.49 Rose, 2010, Notch 1 signaling is active in ovarian cancer, Gynecol. Oncol., 117, 130, 10.1016/j.ygyno.2009.12.003 Scotton, 2002, Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer, Cancer Res., 62, 5930 Shen, 2009, The role of SDF-1/CXCR4 axis in ovarian cancer metastasis, J. Huazhong. Univ. Sci. Technolog. Med. Sci., 29, 363, 10.1007/s11596-009-0320-0 Sulils, 2008, NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL, Blood, 112, 733, 10.1182/blood-2007-12-130096 Wang, 2010, Notch1 expression correlates with tumor differentiation status in ovarian carcinoma, Med. Oncol., 27, 1329, 10.1007/s12032-009-9384-8 Williams, 2008, Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells, Cancer Res., 68, 1889, 10.1158/0008-5472.CAN-07-2181 Zabel, 2011, The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells, Mol. Cancer, 10, 73, 10.1186/1476-4598-10-73